Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Chew

Showing results (201-210 of 214) with videos related to

Pageof 22
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: AbataceptNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical IllnessAdarsh Bhimraj, Yngve Falck-Ytter, Lindsey R Baden, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: InfliximabNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2026
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in AdultsAmy Hirsch Shumaker, Adarsh Bhimraj, Roger Bedimo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2026
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Baricitinib vs. TocilizumabNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
The Journal of Infectious Diseases|July 10, 2020
Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE TrialTomas G Neilan, Kim-Lien Nguyen, Vlad G Zaha, et al.
Cell|December 28, 2021
Discovering dominant tumor immune archetypes in a pan-cancer censusAlexis J Combes, Bushra Samad, Jessica Tsui, et al.
Research Square|November 3, 2020
Global Absence and Targeting of Protective Immune States in Severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2020
Global Absence and Targeting of Protective Immune States in Severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Research Square|April 1, 2025
Combination immunotherapy induces post-intervention control of HIVM J Peluso, D A Sandel, A N Deitchman, et al.
Pageof 22

Showing results (201-210 of 214) with videos related to

Sort By:
Pageof 22
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: AbataceptNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 4, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Pemivibart for Pre-exposure Prophylaxis, Vilobelimab for Critical Illness, and Abatacept or Infliximab for Severe or Critical IllnessAdarsh Bhimraj, Yngve Falck-Ytter, Lindsey R Baden, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 20, 2025
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: InfliximabNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2026
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Antiviral Treatment for Mild to Moderate COVID-19 in AdultsAmy Hirsch Shumaker, Adarsh Bhimraj, Roger Bedimo, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 1, 2026
2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on the Treatment and Management of COVID-19: Baricitinib vs. TocilizumabNandita Nadig, Adarsh Bhimraj, Kelly Cawcutt, et al.
The Journal of Infectious Diseases|July 10, 2020
Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE TrialTomas G Neilan, Kim-Lien Nguyen, Vlad G Zaha, et al.
Cell|December 28, 2021
Discovering dominant tumor immune archetypes in a pan-cancer censusAlexis J Combes, Bushra Samad, Jessica Tsui, et al.
Research Square|November 3, 2020
Global Absence and Targeting of Protective Immune States in Severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2020
Global Absence and Targeting of Protective Immune States in Severe COVID-19Alexis J Combes, Tristan Courau, Nicholas F Kuhn, et al.
Research Square|April 1, 2025
Combination immunotherapy induces post-intervention control of HIVM J Peluso, D A Sandel, A N Deitchman, et al.
Pageof 22